TITLE
CD133+ and CD133- glioblastoma-derived cancer stem cell lines

SUMMARY
Comparison of CD133+ and CD133- glioblastoma-derived cancer stem cells (CSC). Both CSC subpopulations were derived from primary glioblastomas. Results provide insight into the role of CD133+ and CD133- CSCs in the pathogenesis of glioblastoma.

ORGANISM
Homo sapiens

PLATFORM
GPL570 : [HG-U133_Plus_2] Affymetrix Human Genome U133 Plus 2.0 Array

CITATIONS
Beier D, Hau P, Proescholdt M, Lohmeier A et al. CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res 2007 May 1;67(9):4010-5. PMID:Â  17483311

